Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(4.11)
# 1,639
Out of 4,421 analysts
117
Total ratings
38.4%
Success rate
12.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintained: Buy | $101 | $44.51 | +126.92% | 10 | Jun 7, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | n/a | $4.95 | - | 1 | Apr 27, 2026 | |
| ZLDPF Zealand Pharma A/S | Downgraded: Hold | n/a | $44.75 | - | 4 | Mar 6, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | n/a | $93.87 | - | 1 | Mar 1, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | n/a | $55.15 | - | 7 | Feb 20, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | n/a | $19.21 | - | 9 | Dec 4, 2025 | |
| EVMN Evommune | Initiated Coverage: Buy | n/a | $21.36 | - | 1 | Dec 1, 2025 | |
| MDGL Madrigal Pharmaceuticals | Upgraded: Buy | n/a | $505.75 | - | 4 | Nov 4, 2025 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | n/a | $4.50 | - | 2 | Oct 15, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | n/a | $8.49 | - | 6 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4505 | - | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.70 | - | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.05 | - | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.43 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $81.82 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.22 | n/a | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.65 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $2.8 | $3.05 | n/a | 10 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.28 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3.5 | $2.15 | n/a | 3 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $23 | $4.07 | n/a | 8 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $62 | $10.88 | n/a | 8 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $26.21 | n/a | 8 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.96 | n/a | 8 | Aug 5, 2021 |
Structure Therapeutics
Jun 7, 2026
Maintained: Buy
Price Target: $101
Current: $44.51
Upside: +126.92%
Shattuck Labs
Apr 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.95
Upside: -
Zealand Pharma A/S
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.75
Upside: -
Veradermics
Mar 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $93.87
Upside: -
Travere Therapeutics
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.15
Upside: -
MoonLake Immunotherapeutics
Dec 4, 2025
Maintained: Buy
Price Target: n/a
Current: $19.21
Upside: -
Evommune
Dec 1, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $21.36
Upside: -
Madrigal Pharmaceuticals
Nov 4, 2025
Upgraded: Buy
Price Target: n/a
Current: $505.75
Upside: -
Aclaris Therapeutics
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.50
Upside: -
ORIC Pharmaceuticals
Sep 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.49
Upside: -
Sep 15, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.4505
Upside: -
Aug 15, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $14.70
Upside: -
Jul 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $6.05
Upside: -
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $31.43
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $81.82
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $53.22
Upside: n/a
Jan 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $10.65
Upside: n/a
Aug 11, 2023
Maintained: Buy
Price Target: $14 → $2.8
Current: $3.05
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $5.28
Upside: n/a
Jan 10, 2023
Maintained: Buy
Price Target: $5 → $3.5
Current: $2.15
Upside: n/a
Sep 12, 2022
Maintained: Buy
Price Target: $27 → $23
Current: $4.07
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $58 → $62
Current: $10.88
Upside: n/a
Sep 21, 2021
Maintained: Buy
Price Target: $44
Current: $26.21
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $22
Current: $1.96
Upside: n/a